Prelude Capital Management’s Ibere Pharmaceuticals IBER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,000
Closed -$98K 1964
2022
Q1
$98K Hold
10,000
﹤0.01% 1130
2021
Q4
$97K Sell
10,000
-3,634
-27% -$35.3K ﹤0.01% 1362
2021
Q3
$133K Buy
13,634
+3,634
+36% +$35.5K ﹤0.01% 1110
2021
Q2
$97K Buy
+10,000
New +$97K ﹤0.01% 1202